Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme Court blocked a prior deal. The bankrupt company announced Tuesday it had filed a Chapter 11 Plan of Reorganization in the U.S.…
Source link
2025-03-20
